Category Archives: Events

ePharma Summit: Turning Big Data into Better Content

By Ben Comer | Published: March 6, 2013

Physicians and patients are more intimately engaged with their digital devices than ever before, but the content pharma delivers is either rigidly scientific or numbingly bland. Can stronger analytical processes and more data produce a scalable human voice for individual customers?

Also posted in Advertising, E-Media, FDA, Marketing, Patient Communication, Regulatory, Sales, Strategy, Technology, healthcare, multimedia, social media | Tagged digital marketing, ePharma Summit, patient education, patient engagement, Professional Marketing | Leave a comment

US Cuts Could Jeopardize Global Health Innovations, Says Report

By Julian Upton | Published: February 20, 2013

Cuts to US global health and research programs for diseases such as AIDS, tuberculosis and malaria risk derailing the innovations crucial to fighting these diseases, according a new report by the Global Health Technologies Coalition.

Posted in Events | Tagged AIDS, Bill & Melinda Gates Foundation, Cuts, malaria, PEPFAR, Tuberculosis | Leave a comment

IOM: Curb Fake Meds through Track-and-Trace, but Forget "Counterfeits"

By Jill Wechsler | Published: February 19, 2013

A new report from the Institute of Medicine (IOM) has drawn a lot of attention to the public health dangers of falsified and substandard medicines around the world. The aim is to build support for a range of activities that can limit the spread of fake medicines in the U.S. and help developing nations strengthen [...]

Also posted in Anti-counterfeiting, FDA, Manufacturing, R&D, Regulatory, Safety, Strategy, Supply Chain, compliance | Tagged Institute of Medicine, IOM, National Institute of Standards and Technology, NIST, Public health, Supply Chain | Leave a comment

J.P. Morgan: Suits Take San Francisco

By Ben Comer | Published: January 10, 2013

The perennial fat got chewed during the first two days at J.P. Morgan’s annual healthcare conference – buy back stock or raise dividends? – and the usual suspects lurked, but newcomers like Walgreens and not-so-pharma companies like Life Technologies packed the presentation halls and corridors, demonstrating investor and general interest in new ideas, products and [...]

Also posted in Biotech, Deals, Global, R&D, Regulatory, Strategy, Technology, healthcare, leadership, pricing | Tagged J.P. Morgan | Leave a comment

New York Pharma Forum: Together We Stand

By Ben Comer | Published: December 13, 2012

Participants in the 23rd Annual NYPF General Assembly last Friday outlined the many challenges facing industry, and the importance of collaboration as a way to move forward.

Also posted in Biotech, People, R&D, Strategy, Technology, leadership | Tagged academia, Biotech, collaboration, innovation, Meetings, Merck, New York City, New York Pharma Forum, NYPF, partnerships, Pharma, Takeda | Leave a comment